Compare Salesforce Inc (CRM) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Zoetis Inc — how do they compare? Salesforce Inc trades at $195.81 (market cap $158.33B), while Zoetis Inc trades at $73.91 (market cap $30.39B). The key difference: Salesforce Inc is far larger — about 5.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.88%). Which is the better fit depends on your goals.
| CRM | ZTS | |
|---|---|---|
Market Cap | $158.33B | $30.39B |
Sector | Technology | Health |
52-Week High | $266.23 | $156.76 |
52-Week Low | $150.12 | $71.91 |
Enterprise Value | $188.38B | $37.95B |
Dividend Yield | 0.91% | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $197.47, down slightly by 0.02% on the day, with a bullish technical signal driven by moving averages. The stock has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $3.88 surpassing the $3.13 estimate. Revenue grew to $37.90B in 2025, and net income margin expanded to 16.35%. Analyst consensus is strongly bullish with a $231.91 price target, though recent news highlights sector-wide software stock volatility amid AI-driven market shifts.
The outlook remains positive given strong fundamentals and AI monetization progress, but risks include competitive pressures and macroeconomic sensitivity. The stock offers growth potential at a reasonable valuation (P/E 22.88), supported by robust cash flow and institutional buy-in, though investors should monitor execution on AI initiatives and broader tech sector sentiment.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
